• Top cardiology stories: New advances in preventive cardiology, FDA action on edible oils for CV health

    14 days ago - By Healio

    The top story this week in cardiology was a Healio exclusive commentary on the new 2018 cholesterol guidelines.
    In addition, the FDA announced that it will allow manufacturers of certain edible oils to make qualified health claims that their products have CV benefits.
    Rounding out the most-read stories were research presented at the American Heart Association Scientific Sessions, including data indicating that empagliflozin reduces left ventricular mass in type 2 diabetes, higher free thyroxine levels within normal range confer elevated atrial fibrillation risk and cardiac arrest-induced
    Read more ...